Led by a highly experienced team of specialist doctors and drug development experts, our focus is on developing proprietary natural psilocybin drug development and treatment protocols to treat the full spectrum of mental health disorders. This ranges from stress and anxiety as a result of the current state of the world, to existential distress as part of a broader palliative care program.
To prove the efficacy of our naturally derived compounds, in comparison to studies undertaken using synthetically produced molecules, we will
undertake rigorous clinical trials at universities and research hospitals, leveraging our extensive networks and partnerships in Canada and
Jamaica. We will also partner with established providers of psilocybin-assisted therapeutic retreat
experiences to conduct observational studies.